Additional file 16: of Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma

Hsu, Cheng-Lung; Lui, Kar-Wai; Chi, Lang-Ming; Kuo, Yung-Chia; Chao, Yin-Kai; Yeh, Chun-Nan; Lee, Li-Yu; Huang, Yenlin; Lin, Tung-Liang; Huang, Mei-Yuan; Lai, Yi-Ru; Yeh, Yuan-Ming; Fan, Hsien-Chi; Lin, An-Chi; Lu, Yen-Jung; Hsieh, Chia-Hsun; Chang, Kai-Ping; Tsang, Ngan-Ming; Wang, Hung-Ming; Chang, Alex; Chang, Yu-Sun; Li, Hsin-Pai

doi:10.6084/m9.figshare.7116329.v1

13046_2018_873_MOESM16_ESM.pdf (364.27 kB)

Additional file 16: of Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma

journal contribution

posted on 2018-09-20, 05:00 authored by Cheng-Lung Hsu, Kar-Wai Lui, Lang-Ming Chi, Yung-Chia Kuo, Yin-Kai Chao, Chun-Nan Yeh, Li-Yu Lee, Yenlin Huang, Tung-Liang Lin, Mei-Yuan Huang, Yi-Ru Lai, Yuan-Ming Yeh, Hsien-Chi Fan, An-Chi Lin, Yen-Jung Lu, Chia-Hsun Hsieh, Kai-Ping Chang, Ngan-Ming Tsang, Hung-Ming Wang, Alex Chang, Yu-Sun Chang, Hsin-Pai Li

Table S8. Clinical characteristics of metastatic NPC patients with FFPE tissue cyclin D1 immnunohistochemical staining (2002â2016). (PDF 364 kb)

Funding

Chang Gung Memorial Hospital, Linkou

History

Usage metrics

Keywords

Nasopharyngeal carcinoma Patient derived xenograft EBV Whole-exome sequencing CDK4/6 inhibitor RNA sequencing

Licence

CC BY + CC0

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 16: of Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma

Funding

Chang Gung Memorial Hospital, Linkou

History

Usage metrics

Categories

Keywords

Licence

Exports